Influence of exposure to electromagnetic field on the cardiovascular system.
Abstract
1 We examined whether extremely low frequency electromagnetic fields (ELF-EMF) affect the basal level of cardiovascular parameters and influence of drugs acting on the sympathetic nervous system. 2 Male rats were exposed to sham control and EMF (60 Hz, 20 G) for 1 (MF-1) or 5 days (MF-5). We evaluated the alterations of blood pressure (BP), pulse pressure (PP), heart rate (HR), and the PR interval, QRS interval and QT interval on the electrocardiogram and dysrhythmic ratio in basal level and dysrhythmia induced by beta-adrenoceptor agonists. 3 In terms of the basal levels, there were no statistically significant differences among control, MF-1 and MF-5 in PR interval, QRS interval, mean BP, HR and PP. However, the QT interval, representing ventricular repolarization, was significantly reduced by MF-1 (P < 0.05). 4 (-)-Dobutamine (beta1-adrenoceptor-selective agonist)-induced tachycardia was significantly suppressed by ELF-EMF exposure in MF-1 for the increase in HR (DeltaHR), the decrease in QRS interval (DeltaQRS) and the decrease in QT (DeltaQT) interval. Adrenaline (nonselective beta-receptor agonist)-induced dysrhythmia was also significantly suppressed by ELF-EMF in MF-1 for the number of missing beats, the dysrhythmic ratio, and the increase in BP and PP. 5 These results indicated that 1-day exposure to ELF-EMF (60 Hz, 20 G) could suppress the increase in HR by affecting ventricular repolarization and may have a down-regulatory effect on responses of the cardiovascular system induced by sympathetic agonists.
AI evidence extraction
Main findings
In basal measurements, there were no statistically significant differences among sham control, 1-day exposure, and 5-day exposure groups for PR interval, QRS interval, mean BP, HR, and PP; QT interval was significantly reduced after 1-day exposure. Under sympathetic agonist challenge, 1-day ELF-EMF exposure significantly suppressed dobutamine-induced tachycardia-related changes and suppressed adrenaline-induced dysrhythmia measures (including missing beats, dysrhythmic ratio, and BP/PP increases).
Outcomes measured
- Blood pressure (BP)
- Pulse pressure (PP)
- Heart rate (HR)
- ECG PR interval
- ECG QRS interval
- ECG QT interval
- Dysrhythmic ratio
- Dobutamine-induced tachycardia responses (DeltaHR, DeltaQRS, DeltaQT)
- Adrenaline-induced dysrhythmia outcomes (missing beats, dysrhythmic ratio, BP and PP increases)
Limitations
- Sample size not reported in the provided abstract/metadata
- Animal study; generalizability to humans not addressed in the provided abstract
- Only one exposure condition reported (60 Hz, 20 G)
- Effects appear dependent on exposure duration (not clearly observed for 5-day exposure in the abstract)
Suggested hubs
-
elf-emf
(0.9) Study examines extremely low frequency EMF (60 Hz) exposure effects.
-
cardiovascular-effects
(0.75) Outcomes include BP, HR, ECG intervals, and dysrhythmia measures.
View raw extracted JSON
{
"study_type": "animal",
"exposure": {
"band": "ELF",
"source": null,
"frequency_mhz": 0.059999999999999997779553950749686919152736663818359375,
"sar_wkg": null,
"duration": "1 day or 5 days"
},
"population": "Male rats",
"sample_size": null,
"outcomes": [
"Blood pressure (BP)",
"Pulse pressure (PP)",
"Heart rate (HR)",
"ECG PR interval",
"ECG QRS interval",
"ECG QT interval",
"Dysrhythmic ratio",
"Dobutamine-induced tachycardia responses (DeltaHR, DeltaQRS, DeltaQT)",
"Adrenaline-induced dysrhythmia outcomes (missing beats, dysrhythmic ratio, BP and PP increases)"
],
"main_findings": "In basal measurements, there were no statistically significant differences among sham control, 1-day exposure, and 5-day exposure groups for PR interval, QRS interval, mean BP, HR, and PP; QT interval was significantly reduced after 1-day exposure. Under sympathetic agonist challenge, 1-day ELF-EMF exposure significantly suppressed dobutamine-induced tachycardia-related changes and suppressed adrenaline-induced dysrhythmia measures (including missing beats, dysrhythmic ratio, and BP/PP increases).",
"effect_direction": "mixed",
"limitations": [
"Sample size not reported in the provided abstract/metadata",
"Animal study; generalizability to humans not addressed in the provided abstract",
"Only one exposure condition reported (60 Hz, 20 G)",
"Effects appear dependent on exposure duration (not clearly observed for 5-day exposure in the abstract)"
],
"evidence_strength": "low",
"confidence": 0.7800000000000000266453525910037569701671600341796875,
"peer_reviewed_likely": "yes",
"keywords": [
"ELF-EMF",
"60 Hz",
"20 G",
"rats",
"cardiovascular",
"electrocardiogram",
"QT interval",
"ventricular repolarization",
"dobutamine",
"adrenaline",
"sympathetic nervous system",
"dysrhythmia"
],
"suggested_hubs": [
{
"slug": "elf-emf",
"weight": 0.90000000000000002220446049250313080847263336181640625,
"reason": "Study examines extremely low frequency EMF (60 Hz) exposure effects."
},
{
"slug": "cardiovascular-effects",
"weight": 0.75,
"reason": "Outcomes include BP, HR, ECG intervals, and dysrhythmia measures."
}
]
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.